Cognition Therapeutics Completes Oversubscribed $12 Million Series B Financing



Comments are closed.

Leading Consumer 3D Printing Company, New Matter, Raises $6.5M in Series A Funding
Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration
Tetra Therapeutics announces positive topline results from Phase 2 study of BPN14770 in patients with Fragile X Syndrome
Vium Expands Digital Vivarium Technology and Closes $24m Series B Financing